Non-viral gene therapy for bone tissue engineering

Biotechnology and Genetic Engineering Reviews

Volumn 29, Issue 2, 2013, Pages 206-220

  Wegman, Fiona ^a   Cumhur Oner F ^a   Dhert, Wouter J A ^a,b   Alblas, Jacqueline ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Bone; Gene activated matrix; Gene therapy; Multipotent stromal cell (MSC); Non viral; Osteogenicity

Indexed keywords

BONE; GENE TRANSFER; RNA; TISSUE REGENERATION;

BONE REGENERATION; BONE TISSUE ENGINEERING; GENE-ACTIVATED MATRIX; IN-VIVO; MULTIPOTENT STROMAL CELL; NONVIRAL; NONVIRAL GENE THERAPY; OSTEOGENICITY; STROMAL CELLS; TRANSFECTION AGENTS;

GENE THERAPY;

BONE MORPHOGENETIC PROTEIN 2; CASEIN KINASE II; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOSOME; MESSENGER RNA; MINICIRCLE DNA; NANOPARTICLE; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE; PLASMID DNA; POLYGLACTIN; POLYLACTIC ACID; POLYMER; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR OSTERIX; VIRUS ENVELOPE PROTEIN;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ALLOTRANSPLANTATION; ARTICLE; BIOCOMPATIBILITY; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; BONE TISSUE; BONE TISSUE ENGINEERING; CYTOTOXICITY; DNA VECTOR; ENZYME REPLACEMENT; EX VIVO GENE TRANSFER; GENE TARGETING; HUMAN; IN VIVO GENE TRANSFER; MYOBLAST; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; RETROVIRUS; RNA INTERFERENCE; TISSUE ENGINEERING; TRANSGENE; TRANSIENT EXPRESSION; CELL DIFFERENTIATION; CYTOLOGY; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES;

BONE REGENERATION; CELL DIFFERENTIATION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; TISSUE ENGINEERING; TRANSFECTION;

EID: 84887490741     PISSN: 02648725     EISSN: None     Source Type: Journal    
DOI: 10.1080/02648725.2013.801227     Document Type: Article

References (88)

1. Aggarwal, R., Pompili, V. J., & Das, H. (2010). Genetic modification of ex-vivo expanded stem cells forclinical application. Frontiers in Bioscience, 15, 854-871.
2. Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815-1822.
3. Ahn, H. H., Lee, J. H., Kim, K. S., Lee, J. Y., Kim, M. S., Khang, G., ... Lee, H. B. (2008). Polyethyleneimine-mediated gene delivery into human adipose derived stem cells. Biomaterials, 29, 2415-2422.
4. Arthur, A., Zannettino, A., & Gronthos, S. (2009). The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. Journal of Cell Physiology, 218, 237-245.
5. Blum, J. S., Barry, M. A., Mikos, A. G., & Jansen, J. A. (2003). In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Human Gene Therapy, 14, 1689-1701.
6. Bonadio, J., Smiley, E., Patil, P., & Goldstein, S. (1999). Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nature Medicine, 5, 753-759.
7. Bose, S., & Tarafder, S. (2012). Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomaterialia, 8, 1401-1421.
8. Bourgeat-Lami, E. (2002). Organic-inorganic nanostructured colloids. Journal of Nanoscience and Nanotechnology, 2, 1-24.
9. Carragee, E. J., Hurwitz, E. L., & Weiner, B. K. (2011). A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine Journal, 11, 471-491.
10. Chew, S. A., Kretlow, J. D., Spicer, P. P., Edwards, A. W., Baggett, L. S., Tabata, Y., ... Mikos, A. G. (2011). Delivery of plasmid DNA encoding bone morphogenetic protein-2 with a biodegradable branched polycationic polymer in a critical-size rat cranial defect model. Tissue Engineering Part A, 17, 751-763.
11. Chimutengwende-Gordon, M., & Khan, W. S. (2012). Advances in the use of stem cells and tissue engineering applications in bone repair. Current Stem Cell Research and Therapy, 7, 122-126.
12. Choi, Y. H., Liu, F., Choi, J. S., Kim, S. W., & Park, J. S. (1998). Polyethylene glycol-grafted poly-L lysine as polymeric gene carrier. Journal of Controlled Release, 54, 39-48.
13. Chowdhury, E. H., & Akaike, T. (2005). Bio-functional inorganic materials: An attractive branch of gene-based nano-medicine delivery for 21st century. Current Gene Therapy, 5, 669-676.
14. Clements, B. A., Incani, V., Kucharski, C., Lavasanifar, A., Ritchie, B., & Uludaǧ, H. (2007). A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cells. Biomaterials, 28, 4693-4704.
15. Clinical trial database. Retrieved from http://www.wiley.com/legacy/ wileychi/genmed/clinical/
16. Corsi, K., Chellat, F., Yahia, L., & Fernandes, J. C. (2003). Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials, 24, 1255-1264.
17. Dang, J. M., & Leong, K. W. (2006). Natural polymers for gene delivery and tissue engineering. Advanced Drug Delivery Reviews, 58, 487-499.
18. Deng, M., James, R., Laurencin, C. T., & Kumbar, S. G. (2012). Nanostructured polymeric scaffolds for orthopaedic regenerative engineering. IEEE Transactions in Nanobioscience, 11, 3-14.
19. Düzgüneş, N., De Ilarduya, C. T., Simões, S., Zhdanov, R. I., Konopka, K., & Pedroso de Lima, M. C. (2003). Cationic liposomes for gene delivery: Novel cationic lipids and enhancement by proteins and peptides. Current Medicinal Chemistry, 10, 1213-1220.
20. Fang, J., Zhu, Y. Y., Smiley, E., Bonadio, J., Rouleau, J. P., Goldstein, S. A., ... Roessler, B. J. (1996). Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proceedings of the National Academy of Science of the United States of America, 93, 5753-5758.
21. Ferreira, E., Potier, E., Logeart-Avramoglou, D., Salomskaite-Davalgiene, S., Mir, L. M., & Petite, H. (2008). Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Therapy, 15, 537-544.
22. Fischer, D., Bieber, T., Li, Y., Elsässer, H. P., & Kissel, T. (1999). A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharmaceutical Research, 16, 1273-1279.
23. Franceschi, R. T., Wang, D., Krebsbach, P. H., & Rutherford, R. B. (2000). Gene therapy for bone formation: In vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. Journal of Cell Biochemistry, 78, 476-486.
24. Garcia-Fuentes, M., & Alonso, M. J. (2012). Chitosan-based drug nanocarriers: Where do we stand? Journal of Controlled Release, 161, 496-504.
25. Gill, D. R., Pringle, I. A., & Hyde, S. C. (2009). Progress and prospects: The design and production of plasmid vectors. Gene Therapy, 16, 165-171.
26. Glassman, S. D., Gum, J. L., Crawford, C. H. 3rd, Shields, C. B., & Carreon, L. Y. (2011). Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear. Spine Journal, 11, 522-526.
27. Godbey, W. T., Barry, M. A., Saggau, P., Wu, K. K., & Mikos, A. G. (2000). Poly(ethylenimine)-mediated transfection: A new paradigm for gene delivery. Journal of Biomedical Materials Research, 51, 321-328.
28. Gwak, S. J., & Kim, B. S. (2008). Poly(lactic-co-glycolic acid) nanosphere as a vehicle for gene delivery to human cord blood-derived mesenchymal stem cells: comparison with polyethylenimine. Biotechnology Letters, 30, 1177-1182.
29. Han, S. W., Nakamura, C., Kotobuki, N., Obataya, I., Ohgushi, H., Nagamune, T., & Miyake, J. (2008). High-efficiency DNA injection into a single human mesenchymal stem cell using a nanoneedle and atomic force microscopy. Nanomedicine, 4, 215-225.
30. He, X., Dziak, R., Mao, K., Genco, R., Swithart, M., Li, C., & Yang, S. (2013). Integration of a novel injectable nano calcium sulfate/alginate scaffold and BMP2-gene modified MSCs for bone regeneration. Tissue Engineering Part A, 19, 508-518.
31. Hedley, M. L., Curley, J., & Urban, R. (1998). Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nature Medicine, 4, 365-368.
32. Hoekstra, D., Rejman, J., Wasungu, L., Shi, F., & Zuhorn, I. (2007). Gene delivery by cationic lipids: In and out of an endosome. Biochemical Society Transactions, 35, 68-71.
33. Humbert, J. M., & Halary, F. (2012). Viral and non-viral methods to genetically modify dendritic cells. Current Gene Therapy, 12, 127-136.
34. Hyde, S. C., Pringle, I. A., Abdullah, S., Lawton, A. E., Davies, L. A., Varathalingam, A., ... Gill, D. R. (2008). CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nature Biotechnology, 26, 549-551.
35. Incani, V., Tunis, E., Clements, B. A., Olson, C., Kucharski, C., Lavasanifar, A., & Uludag, H. (2007). Palmitic acid substitution on cationic polymers for effective delivery of plasmid DNA to bone marrow stromal cells. Journal of Biomedical Material Research A, 81, 493-504.
36. Kasper, F. K., Kushibiki, T., Kimura, Y., Mikos, A. G., & Tabata, Y. (2005). in vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres. Journal of Controlled Release, 107, 547-561.
37. Kasper, F. K., Young, S., Tanahashi, K., Barry, M. A., Tabata, Y., Jansen, J. A., & Mikos, A. G. (2006). Evaluation of bone regeneration by DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in a critical-sized calvarial defect. Journal of Biomedical Material Research A, 78, 335-342.
38. Kawai, M., Maruyama, H., Bessho, K., Yamamoto, H., Miyazaki, J., & Yamamoto, T. (2009). Simple strategy for bone regeneration with a BMP-2/7 gene expression cassette vector. Biochemical Biophysiology Research Community, 390, 1012-1017.
39. Kay, M. A. (2011). State-of-the-art gene-based therapies: the road ahead. Nature Review Genetics, 12, 316-328.
40. Kempen, D. H., Creemers, L. B., Alblas, J., Lu, L., Verbout, A. J., Yaszemski, M. J., & Dhert, W. J. (2010). Growth factor interactions in bone regeneration. Tissue Engineering Part B Reviews, 16, 551-566.
41. Klyushnenkova, E., Mosca, J. D., Zernetkina, V., Majumdar, M. K., Beggs, K. J., Simonetti, D. W., ... McIntosh, K. R. (2005). T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. Journal Biomedical Science, 12, 47-57.
42. Kong, H. J., Kim, E. S., Huang, Y. C., & Mooney, D. J. (2008). Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA. Pharmaceutical Research, 25, 1230-1238.
43. Krebs, M. D., Salter, E., Chen, E., Sutter, K. A., & Alsberg, E. (2010). Calcium phosphate-DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis. Journal of Biomedical Material Research A, 92, 1131-1138.
44. Lai, Q. G., Yuan, K. F., Xu, X., Li, D. R., Li, G. J., Wei, F. L., ... Li, S. (2011). Transcription factor osterix modified bone marrow mesenchymal stem cells enhance callus formation during distraction osteogenesis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 111, 412-419.
45. Lee, S. J., Kang, S. W., Do, H. J., Han, I., Shin, D. A., Kim, J. H., & Lee, S. H. (2010). Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells. Biomaterials, 31, 5652-5659.
46. Lei, Y., Huang, S., Sharif-Kashani, P., Chen, Y., Kavehpour, P., & Segura, T. (2010). Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds. Biomaterials, 31, 9106-9116.
47. Lim, K. I. (2012). Retroviral integration profiles: Their determinants and implications for gene therapy. BMB Reports, 45, 207-212.
48. Long, J., Li, P., Du, H. M., Liu, L., Zheng, X. H., Lin, Y. F., ... Tian, W. D. (2011). Effects of bone morphogenetic protein 2 gene therapy on new bone formation during mandibular distraction osteogenesis at rapid rate in rabbits. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 112, 50-57.
49. Lustig, L. R., & Akil, O. (2012). Cochlear gene therapy. Current Opinion in Neurology, 25, 57-60.
50. Madeira, C., Mendes, R. D., Ribeiro, S. C., Boura, J. S., Aires-Barros, M. R., da Silva, C. L., & Cabral, J. M. (2010). Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy. Journal of Biomedicine and Biotechnology, 2010, 735349. doi:10.1155/2010/735349
51. Martin, T., Parker, S. E., Hedstrom, R., Le, T., Hoffman, S. L., Norman, J., ... Lew, D. (1999). Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection. Human Gene Therapy, 10, 759-768.
52. McCanless, J. D., Jennings, L. K., Cole, J. A., Bumgardner, J. D., & Haggard, W. O. (2011). In vitro differentiation and biocompatibility of mesenchymal stem cells on a novel platelet releasate-containing injectable composite. Journal Biomedical Material Research A, 100, 220-229.
53. McKee, M. D., Nakano, Y., Masica, D. L., Gray, J. J., Lemire, I., Heft, R., ... Millán, J. L. (2011). Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia. Journal of Dental Research, 90, 470-476.
54. Mehier-Humbert, S., & Guy, R. H. (2005). Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Advanced Drug Delivery Reviews, 57, 733-753.
55. Mingozzi, F., & High, K. A. (2012). Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges. Nature Reviews Genetics, 12, 341-355.
56. Mintzer, M. A., & Simanek, E. E. (2009). Nonviral vectors for gene delivery. Chemistry Reviews, 109, 259-302.
57. Montiel-Equihua, C. A., Thrasher, A. J., & Gaspar, H. B. (2012). Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency. Current Gene Therapy, 12, 57-65.
58. Moreira, C., Oliveira, H., Pires, L. R., Simões, S., Barbosa, M. A., & Pêgo, A. P. (2009). Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone. Acta Biomaterials, 5, 2995-3006.
59. Park, D. J., Choi, J. H., Leong, K. W., Kwon, J. W., & Eun, H. S. (2007). Tissue-engineered bone formation with gene transfer and mesenchymal stem cells in a minimally invasive technique. Laryngoscope, 117, 1267-1271.
60. Park, J. S., Na, K., Woo, D. G., Yang, H. N., Kim, J. M., Kim, J. H., Chung, H. M., & Park, K. H. (2010). Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells. Biomaterials, 31, 124-132.
61. Park, S., Kim, Y. S., Kim, W. B., & Jon, S. (2009). Carbon nanosyringe array as a platform for intracellular delivery. Nanotechnology Letters, 9, 1325-1329.
62. Park, S. J., & Na, K. (2012). The transfection efficiency of photosensitizer-induced gene delivery to human MSCs and internalization rates of EGFP and Runx2 genes. Biomaterials, 33, 6485-6494.
63. Park, T. G., Jeong, J. H., & Kim, S. W. (2006). Current status of polymeric gene delivery systems. Advanced Drug Delivery Reviews, 58, 467-486.
64. Parveen, S., Misra, R., & Sahoo, S. K. (2012). Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine, 8, 147-166.
65. Reckhenrich, A. K., Koch, C., Egaña, J. T., & Plank, C. (2012). The use of non-viral gene vectors for bioactive poly-(D, L-lactide) implant surfaces in bone tissue engineering. European Cells and Materials, 23, 441-448.
66. Reiser, J., Zhang, X. Y., Hemenway, C. S., Mondal, D., Pradhan, L., & La Russa, V. F. (2005). Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opinion Biological Therapy, 5, 1571-1584.
67. Sakuma, T., Barry, M. A., & Ikeda, Y. (2012). Lentiviral vectors: Basic to translational. Biochemical Journal, 443, 603-618.
68. Santos, J. L., Pandita, D., Rodrigues, J., Pêgo, A. P., Granja, P. L., & Tomás, H. (2012). Nonviral gene delivery to mesenchymal stem cells: Methods, strategies and application in bone tissue engineering and regeneration. Current Gene Therapy, 11, 46-57.
69. Saraf, A., Hacker, M. C., Sitharaman, B., Grande-Allen, K. J., Barry, M. A., & Mikos, A. G. (2008). Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells. Biomacromolecules, 9, 818-827.
70. Shea, L. D., Smiley, E., Bonadio, J., & Mooney, D. J. (1999). DNA delivery from polymer matrices for tissue engineering. Nature Biotechnology, 17, 551-554.
71. Sheyn, D., Kallai, I., Tawackoli, W., Cohn Yakubovich, D., Oh, A., Su, S., ... Gazit, D. (2011). Gene modified adult stem cells regenerate vertebral bone defect in a rat model. Molecular Pharmaceutics, 8, 1592-1601.
72. Sheyn, D., Pelled, G., Zilberman, Y., Talasazan, F., Frank, J. M., Gazit, D., & Gazit, Z. (2008). Nonvirally engineered porcine adipose tissue-derived stem cells: Use in posterior spinal fusion. Stem cells, 26, 1056-1064.
73. Shimer, A. L., Oner, F. C., & Vaccaro, A. R. (2009). Spinal reconstruction and bone morphogenetic proteins: Open questions. Injury, 40(Suppl 3), S32-38.
74. Smith, D. K. (2008). Dendrimers and the double helix-From DNA binding towards gene therapy. Current Topics in Medicinal Chemistry, 8, 1187-1203.
75. Song, L., Chau, L., Sakamoto, Y., Nakashima, J., Koide, M., & Tuan, R. S. (2004). Electric fieldinduced molecular vibration for noninvasive, high-efficiency DNA transfection. Molecular Therapy, 9, 607-616.
76. Southwood, L. L., Frisbie, D. D., Kawcak, C. E., & McIlwraith, C. W. (2004). Delivery of growth factors using gene therapy to enhance bone healing. Veterinary Surgery, 33, 565-578.
77. Su, C. H., Wu, Y. J., Wang, H. H., & Yeh, H. I. (2012). Nonviral gene therapy targeting cardiovascular system. American Journal of Physiological Heart and Circulation Physiology, 303, H629-638.
78. Tachibana, R., Harashima, H., Ide, N., Ukitsu, S., Ohta, Y., Suzuki, N., ... Kiwada, H. (2002). Quantitative analysis of correlation between number of nuclear plasmids and gene expression activity after transfection with cationic liposomes. Pharmaceutical Research, 19, 377-381.
79. Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003). Progress and problems with the use of viral vectors for gene therapy. Nature Review Genetics, 4, 346-358.
80. Uchimura, E., Yamada, S., Uebersax, L., Fujita, S., Miyake, M., & Miyake, J. (2007). Method for reverse transfection using gold colloid as a nano-scaffold. Journal Bioscience and Bioengineering, 103, 101-103.
81. Warnock, J. N., Daigre, C., & Al-Rubeai, M. (2011). Introduction to viral vectors. Methods in Molecular Biology, 737, 1-25.
82. Wegman, F., Bijenhof, A., Schuijff, L., Oner, F. C., Dhert, W. J., & Alblas, J. (2011). Osteogenic differentiation as a result of BMP-2 plasmid DNA based gene therapy In vitro and in vivo. European Cells and Materials, 21, 230-242.
83. Wegman, F., Geuze, R. E., van der Helm, Y. J., Öner, F. C., Dhert, W. J., & Alblas, J. (2012). Gene delivery of bone morphogenetic protein-2 plasmid DNA promotes bone formation in a large animal model. Journal of Tissue Engineering and Regenerative Medicine. doi:10.1002/term.1571
84. Wiethoff, C. M., & Middaugh, C. R. (2003). Barriers to nonviral gene delivery. Journal of Pharmaceutical Science, 92, 203-217.
85. Wolff, J. A., & Rozema, D. B. (2008). Breaking the bonds: Non-viral vectors become chemically dynamic. Molecular Therapy, 16, 8-15.
86. Yang, F., Green, J. J., Dinio, T., Keung, L., Cho, S. W., Park, H., Langer, R., & Anderson, D. G. (2009). Gene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors. Gene Therapy, 16, 533-546.
87. Yun, Y. R., Jang, J. H., Jeon, E., Kang, W., Lee, S., Won, J. E., ... Wall, I. (2012). Administration of growth factors for bone regeneration. Regenerative Medicine, 7, 369-385.
88. Zhang, G., Guo, B., Wu, H., Tang, T., Zhang, B. T., Zheng, L., ... Qin, L. (2012). A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nature Medicine, 18, 307-314.